13 Nov 2026, 08:48
Company Update—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 13 Nov 2026, 08:48 | PKD Program - Enrolment Target Met | Company Update | — | 11001 | |
| 12 Nov 2026, 13:24 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 12 Nov 2026, 08:26 | 2026 Annual General Meeting Program and CEO Presentation | Presentations | — | 03026, 15001 | |
| 9 Nov 2026, 16:43 | Notification regarding unquoted securities - PYC | Securities Administration | — | 06021 | |
| 5 Nov 2026, 16:18 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 5 Nov 2026, 08:49 | Annual General Meeting - Conference Link | Presentations | — | 08001, 14014 | |
| 3 Nov 2026, 16:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 30 Oct 2026, 16:25 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 30 Oct 2026, 08:47 | Exercise of Options and Cleansing Notice | Securities Administration | — | 06018 | |
| 30 Oct 2026, 08:39 | Application for quotation of securities - PYC | Securities Administration | — | 06020 | |
| 29 Oct 2026, 08:38 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 23 Oct 2026, 08:21 | PKD Program - ASN Presentation | Presentations | — | 03026 | |
| 16 Oct 2026, 13:49 | Exercise of Options and Cleansing Notice | Securities Administration | — | 06018 | |
| 12 Oct 2026, 08:36 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 8 Oct 2026, 13:50 | Application for quotation of securities - PYC | Securities Administration | — | 06020 | |
| 8 Oct 2026, 13:48 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 7 Oct 2026, 08:42 | PKD Program - Presentation of Data at ASN Conference | Company Update | MS | 11001 | |
| 2 Oct 2026, 08:57 | RP11 PROGRAM - PRESENTATION AT EURETINA 2026 | Presentations | — | 03026 | |
| 11 Sept 2026, 08:25 | PKD - First Patient Dosed in OLE Study | Company Update | — | 11001 | |
| 4 Sept 2026, 17:10 | S&P DJI Announces September 2026 Quarterly Rebalance | Other | MS | — | |
| 4 Sept 2026, 08:30 | Investor Webinar Presentation Q3 2026 | Presentations | — | 03026 | |
| 3 Sept 2026, 08:21 | ADOA Program - Data Presentation | Company Update | — | 03026, 11001 | |
| 2 Sept 2026, 15:52 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 31 Aug 2026, 08:10 | PKD - Presentation of Clinical Safety Data | Presentations | — | 03026 | |
| 28 Aug 2026, 19:14 | 2026 Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 19:12 | Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 19:11 | 2026 Annual Report to Shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 19:08 | Appendix 4E | Financial Results | MS | 03003 | |
| 26 Aug 2026, 16:54 | Notification regarding unquoted securities - PYC | Securities Administration | — | 06021 | |
| 18 Aug 2026, 08:16 | Investor Webinar | Presentations | — | 14014 | |
| 14 Aug 2026, 11:02 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 Aug 2026, 14:42 | Notification regarding unquoted securities - PYC | Securities Administration | — | 06021 | |
| 29 July 2026, 08:45 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 22 July 2026, 08:20 | PKD - Safety Committee Approves Dose Escalation | Company Update | MS | 11001 | |
| 21 July 2026, 08:32 | ADOA Program Update | Company Update | MS | 11001 | |
| 20 July 2026, 19:03 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 20 July 2026, 08:28 | Presentation At 2026 PMS Foundation Family Conference | Presentations | — | 03026 | |
| 15 July 2026, 18:12 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 July 2026, 09:01 | Grant of Patents by the US Patent Office | Company Update | — | 11001 | |
| 7 July 2026, 08:21 | Appointment of Chief Financial Officer | Company Administration | — | 12008 | |
| 18 June 2026, 08:26 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 16 June 2026, 16:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 15 June 2026, 15:01 | Company Secretary Appointment/Resignation | Company Administration | — | 12007 | |
| 12 June 2026, 15:55 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 26 May 2026, 19:23 | Change to CEO remuneration | Company Administration | — | 12008 | |
| 22 May 2026, 09:17 | 2026 Q2 Investor Webinar Presentation | Presentations | — | 03026 | |
| 18 May 2026, 19:06 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 12 May 2026, 09:07 | Investor Webinar | Presentations | — | 14014 | |
| 11 May 2026, 18:56 | Notification of cessation of securities - PYC | Securities Administration | — | 06027 | |
| 7 May 2026, 09:03 | PKD - Initiation of Multiple Dose Clinical Trial | Company Update | MS | 11001 |